Comment on Better Buy: Acadia Pharmaceuticals vs. Eli Lilly

Better Buy: Acadia Pharmaceuticals vs. Eli Lilly

Acadia Pharmaceuticals (NASDAQ: ACAD) aspires to become a big player in the neuroscience market. Eli Lilly (NYSE: LLY) already is one. But aside from their common interest in this therapeutic category, there's little in common between these two drugmakers.Investors considering buying shares of Acadia or Lilly have a stark contrast -- beaten-down biotech, or relatively boring big pharma.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News